Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2000;53:131-136; doi:10.1136/jcp.53.2.131
Copyright © 2000 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
J Clin Pathol 2000; 53:131-136
© 2000 Journal of Clinical Pathology

Temporal artery biopsy: is there any value in examining biopsies at multiple levels?

A Chakrabarty1 and A J Franks2

1 Department of Neuropathology, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, UK
2 Division of Laboratory, Radiology and Pharmacy Services, United Leeds Teaching Hospitals, Leeds, UK

Correspondence to:
Dr Chakrabarty email: arunac{at}pathology.leeds.ac.uk

Aims—To analyse the cost-effectiveness of three strategies for examining temporal artery biopsies based on data from cases examined over the past 10 years.

Methods—Of a total of 172 temporal artery biopsies, five were unsuitable for further analysis, 47 had already had levels cut, and 120 had levels cut as part of the study. All the biopsies were examined blind before and after levels. A tree with eventual diagnostic outcomes for different strategies was constructed and economic and sensitivity analyses performed. Welcan units were used to assess technical workload.

Results—Only one of the 132 initially normal cases and two of 14 diagnosed with periarterial lymphocytic infiltration (PALI) revealed giant cell arteritis after examining the tissue at multiple levels. Fifteen cases (8.9%) showed PALI not previously observed. The marginal cost for each extra case of giant cell arteritis detected was 83.5 Welcan units for a strategy of routine levels on all sections, and 21 Welcan units for a strategy of only cutting levels if PALI was present on the initial section. These costs were sensitive to the frequency of giant cell arteritis in cases with PALI and to the relative extra cost of moving from cutting single section to routine levels.

Conclusions—Routinely examining a temporal artery biopsy at multiple levels does not increase the diagnostic yield of the test, although selective further examination may be indicated in some cases. The significance of PALI is uncertain. The cost-benefit of the different strategies in terms of clinical decision making revolve around the perceived risk inherent in not making a diagnosis of giant cell arteritis.

Key Words: temporal artery biopsy • economic analysis • decision analysis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Mahr, A, Saba, M, Kambouchner, M, Polivka, M, Baudrimont, M, Brocheriou, I, Coste, J, Guillevin, L (2006). Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?. Ann Rheum Dis 65: 826-828 [Abstract] [Full Text]  
  • Calvo-Romero, J M (2003). Giant cell arteritis. Postgrad. Med. J. 79: 511-515 [Abstract] [Full Text]  
  • Cross, S S, Stone, J L (2002). Proactive management of histopathology workloads: analysis of the UK Royal College of Pathologists' recommendations on specimens of limited or no clinical value on the workload of a teaching hospital gastrointestinal pathology service. J. Clin. Pathol. 55: 850-852 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs